Ligand validation:5IQC

51G: gentamicin C1

51G is a Ligand Of Interest in 5IQC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IQC_51G_C_600	75%	69%	0.106	0.939	0.21	0.98	-	1	0	0	100%	1
5IQC_51G_B_600	73%	62%	0.132	0.96	0.25	1.17	-	3	0	0	100%	1
5IQC_51G_A_600	72%	60%	0.125	0.95	0.33	1.18	-	2	0	0	100%	1
5IQC_51G_D_600	63%	47%	0.157	0.954	0.21	1.81	-	3	2	0	100%	0.8182
5IQG_51G_C_600	73%	43%	0.117	0.944	0.22	1.92	-	4	0	0	100%	1
5CFT_51G_A_204	89%	69%	0.074	0.953	0.34	0.84	-	1	0	0	100%	1
7CSJ_51G_A_301	59%	58%	0.142	0.924	0.71	0.91	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.